Analystreport

Cytokinetics (NASDAQ: CYTK) had its price target raised by analysts at HC Wainwright to $24.00. They now have a "buy" rating on the stock.

Cytokinetics, Incorporated  (CYTK) 
Last cytokinetics, incorporated earnings: 3/3 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytokinetics.com/investor-overview